9-10 April 2025
Hotel Airport Okęcie, ul. Komitetu Obrony Robotników 24, Warszawa
As always, it is with great pleasure that we would like to invite you to participate in the 27th edition of the Warsaw Course on Cardiovascular Interventions (WCCI), which takes place under the auspices of the Association of Cardiovascular Interventions of the Polish Cardiac Society and in cooperation with EAPCI and EuroPCR. In order to make our Workshops more attractive, representatives of the Association of Intensive Cardiac Care of the Polish Cardiac Society, the Club 30 of the PCS and the Euro 4C EAPCI Group take part in the creation of the program. This year, WCCI is scheduled for April 24-26 in an on-site formula in the Airport Hotel Okecie in Warsaw.
This year, the main topics are: revascularization of coronary arteries with particular emphasis on multivessel coronary disease (with and without left coronary trunk involvement), the problem of coronary bifurcations and percutaneous treatment of structural heart diseases (including interventions on aortic, mitral and tricuspid valves). The program will include interesting sessions on invasive imaging and functional diagnostics. The program of the Workshops also includes sessions devoted to interventions on the carotid and peripheral arteries. As always, there will be sessions on the borderline of intensive cardiac therapy and invasive cardiology. Once again, we invite you to participate in such well-received mini-workshops: WAR-CHIP (devoted to comprehensive treatments of the highest risk) and WAR-CTO (intended for operators interested in training in recanalization of chronic coronary occlusions).
Traditionally, during the Workshops, live broadcasts from renowned centers in Poland and abroad are planned. There are also scheduled presentations in the „live-in-a box” format. As usual, the WCCI program will be complemented by satellite sessions of the Workshops sponsors.
We cordially invite you to register! Fees and regulations area vailable in the registration form.
8:45-10:15 CAD intravascular imaging race
Session organized in cooperation with EAPCI Young Committee
Session in English
• 9:00-9:12 Case 1 + quiz questions
• 9:12-9:24 Case 2 + quiz questions
9:24-10:00 Live case – PCI with IVUS/OCT guidance
• 10:00-10:10 Take-home message
• 10:10-10:12 Choice of the Session Winners: Panel
• 10:12-10:15 Final comments and advices
10:15-10:25 BREAK
10:25-11:25 OPENING CEREMONY OF THE 29th WARSAW COURSE ON CARDIOVASCULAR INTERVENTIONS
Chair: Robert J. Gil, WCCI Director, Adam Witkowski, WCCI Director & Directors of the: NIK-PIB & PIM MSWiA
Addresses:
• 10:25-10:30 Adam Witkowski, WCCI Co-Director
• 10:30-10:35 Robert J. Gil, President of the Polish Cardiac Society (PCS)
• 10:35-10:40 Representative of ESC
• 10:40-10:43 Representative of EAPCI
• 10:43-10:48 Representative of Association on Cardiovascular Interventions of the PCS
Presentations:
• 10:48-11:03 Keynote WCCI 2025 Lecture: Functional and Intracoronary visualization – milestones of Interventional Cardiology
• 11:03-11:15 Keynote WCCI 2025 Lecture: TBD
• 11:15-11:25 ANDREAS 2024
11:25-11:40 BREAK
• 11.40-12.40 Physiology in the cathlab – what we should know in 2025
Session of the AISN PTK&WCCI
• 11:40-11:52 The role of physiology in obstructive coronary artery disease
Pro and cons for available methods based on clinical cases
• 11:52-12:04 Hyperemic indices
• 12:04-12:16 Non-hyperemic indices
• 12:16-12:28 Angio-based
• Discussion: (15 min)
• 12:28-12:40 The role of physiology in non-obstructive coronary artery disease
12:40-13:40 BREAK (Lunchboxes will be available)
12:40-13:40 Session supported by the unrestricted educational grant by TBD
13:40-13:55 COFFEE BREAK
13:55-14:55 Session organized by DCB Academy and the working group “Modern Technologies of Drug-Eluting Stents and Drug-Coated Balloons” of the Association of Cardiovascular Interventions of the Polish Cardiac Society
• 13:55-14:05 Current management of In-Stent Restenosis – Is there room for DCB after the recent ESC guidelines?
• 14:05-14:15 The new perspectives of DCB in de novo lesions – A 2025 scientific update on the clinical performance of DCB
• 14:15-14:25 Intracoronary imaging-guided DCB intervention – Is this the key to success?
• 14:25-14:35 Role of physiology in DCB-PCI
14:31-14:55 – Live case – robotic-assisted PCI with DEB
(Wspólne dla Galaxy 1 oraz 3)
14:55-15:05 BREAK
15:05-16:35 European Bifurcation Club &WCCI symposium: Coronary bifurcation treatment in 2025
Session in English
15:05-15:45 Live case 1&2 Live from Warsaw & Cracow – Bifurcation stenting with IVUS or OCT.
• 15:45-15:57 Do we have already new devices for bifurcation treatment?
• 15:57-16:09 Unintended stent deformation during bifurcation treatment – how we can deal with
• 16:09-16:21 DEB in bifurcations – is it right time for routine usage?
• 16.21- 16:33 EBC 2025 achievements so far and what is the way forward”
• 16.33-16.35 Summary
16:35-16:45 BREAK
16:45-18:15 Warsaw Course on Complex and High Risk Indicated Patients (WAR-CHIP) organized in cooperation with Euro4C group. Main session.
Session in English
• 16:45-18:15 WARCHIP 25 – session 3: Decalcification tools battle – what is the right choice
• 16:45-16:50 Objectives of the session
• 16:50-17:05 Calcific nodules – orbital atherectomy or lithotripsy
• 17:05-17:20 Superficial calcium – rotational atherectomy or cutting balloon
17:20-17:50 Live case – Complex PCI with LVAD support
• 17:50-18:05 Calcium and imaging – guide for choice
• 18:05-18:15 Take home message
18:45-18:55 BREAK
18:15-19:15 Symposium: Innovations in Cardiology – Let`s have a look what is and will be available in Cath Lab.
Session in English
• 18:15-19:10 Presentations of Industry Innovations
TBD
• 19:10-19:20 Take-home message.
19:15 AISN BOARD MEETING/POSIEDZENIE ZARZĄDU AISN PTK – hot meal will be not available
__________________________________________________
9:00-10:15 Innovations in cardiovascular interventions: state-of the art 2025.
Session under auspices of Club 30 of the PCS
Session in English
• 9:00-9:10 Interventional therapies for pulmonary embolism.
• 9:10-9:20 AI-enhanced intravascular imaging guided PCI.
• 9:20-9:30 Calcium modification – lithotripsy, atherectomy or laser?
• 9:30-9:40 Refractory angina caused by microvascular dysfunction – promise of coronary sinus reducer.
• 9:40-9:50 Mechanical circulatory support for complex interventions and cardiogenic shock.
• 9:50-10:00 Interventional approaches for renal denervation.
• 10:00-10:15 Discussion
10:15-10:25 BREAK
10:25-11:25 OPENING CEREMONY OF THE 29th WARSAW COURSE ON CARDIOVASCULAR INTERVENTIONS
Chair: Robert J. Gil, WCCI Director, Adam Witkowski, WCCI Director & Directors of the: NIK-PIB & PIM MSWiA
Addresses:
• 10:25-10:30 Adam Witkowski, WCCI Co-Director
• 10:30-10:35 Robert J. Gil, President of the Polish Cardiac Society (PCS)
• 10:35-10:40 Representative of ESC
• 10:40-10:43 Representative of EAPCI
• 10:43-10:48 Representative of Association on Cardiovascular Interventions of the PCS
Presentations:
• 10:48-11:03 Keynote WCCI 2025 Lecture: Functional and Intracoronary visualization – milestones of Interventional Cardiology
• 11:03-11:15 Keynote WCCI 2025 Lecture: TBD
• 11:15-11:25 ANDREAS 2024
11:25-11:40 BREAK
• 11.40-12.40 Pulmonary embolism as a cause of heart failure
Session of the ANS & Working Group on Pulmonary Circulation PTK
• 11:40-11:55 Pulmonary embolism and acute right ventricular failure – can we reverse adverse outcome with interventional treatment?
• 11:55-12:10 Pulmonary Embolism Response Teams and National Program for the Treatment of Cardiogenic Shock – how to link it together?
• 12:10-12:25 Chronic thromboembolic pulmonary hypertension – a cause of persistent right ventricular failure that can be effectively treated
• 12:25-12:40 Panel discussion
12:40-13:40 BREAK (Lunchboxes will be available)
12:40-13:40 Session supported by the unrestricted educational grant by TBD
13:40-13:55 COFFEE BREAK
13:55-14:55 Wstrząs … – cogito ergo sum
Sesja AITK PTK
• 13:55-14:07 Wstrząs – klasyfikacja, diagnostyka, różnicowanie
• 14:07-14:19 Kiedy wykonywać diagnostykę inwazyjną u chorych po OHCA
• 14:19-14:31 Wskazania do wspomagania krążenia
• 14:31-14:43 Farmakoterapia wstrząsu
• 14:43-14:55 Dyskusja panelowa
14:55-15:05 BREAK
15:05-16:35 European Bifurcation Club &WCCI symposium: Coronary bifurcation treatment in 2025
Session in English
15:05-15:45 Live case 1&2 Live from Warsaw & Cracow – Bifurcation stenting with IVUS or OCT.
• 15:45-15:57 Do we have already new devices for bifurcation treatment?
• 15:57-16:09 Unintended stent deformation during bifurcation treatment – how we can deal with
• 16:09-16:21 DEB in bifurcations – is it right time for routine usage?
• 16.21- 16:33 EBC 2025 achievements so far and what is the way forward”
• 16.33-16.35 Summary
16:35-16:45 BREAK
16:45-18:15 Warsaw Course on Complex and High Risk Indicated Patients (WAR-CHIP) organized in cooperation with Euro4C group. Main session.
Session in English
16:45-18:15 WARCHIP 25 – session 3: Decalcification tools battle – what is the right choice
• 16:45-16:50 Objectives of the session
• 16:50-17:05 Calcific nodules – orbital atherectomy or lithotripsy
• 17:05-17:20 Superficial calcium – rotational atherectomy or cutting balloon
• 17:20-17:50 Live case – Complex PCI with LVAD support
• 17:50-18:05 Calcium and imaging – guide for choice
• 18:05-18:15 Take home message
18:45-18:55 BREAK
18:15-19:15 Symposium: Innovations in Cardiology – Let`s have a look what is and will be available in Cath Lab.
Session in English
• 18:15-19:10 Presentations of Industry Innovations
TBD
• 19:10-19:20 Take-home message.
19:15 AISN BOARD MEETING/POSIEDZENIE ZARZĄDU AISN PTK – hot meal will be not available
__________________________________________________
8:45-10:15 My most demanding case in 2024. Session under the patronage of the e-journal Interventional Cardiology Academy in cooperation with Club 30 of the PCS.
Session in English
• 8:45-8:52 Case 1
• 8:52-8:55 Discussion
• 8:55-9:02 Case 2
• 9:02-9:05 Discussion
• 9:05-9:12 Case 3
• 9:12-9:15 Discussion
• 9:15-9:22 Case 4
• 9:22-9:25 Discussion
• 9:25-10:15 Voting and announcing the results of the competition for the best clinical case presented.
10:15-10:25 BREAK
10:25-11:25 OPENING CEREMONY OF THE 29th WARSAW COURSE ON CARDIOVASCULAR INTERVENTIONS
Chair: Robert J. Gil, WCCI Director, Adam Witkowski, WCCI Director & Directors of the: NIK-PIB & PIM MSWiA
Addresses:
• 10:25-10:30 Adam Witkowski, WCCI Co-Director
• 10:30-10:35 Robert J. Gil, President of the Polish Cardiac Society (PCS)
• 10:35-10:40 Representative of ESC
• 10:40-10:43 Representative of EAPCI
• 10:43-10:48 Representative of Association on Cardiovascular Interventions of the PCS
Presentations:
• 10:48-11:03 Keynote WCCI 2025 Lecture: Functional and Intracoronary visualization – milestones of Interventional Cardiology
• 11:03-11:15 Keynote WCCI 2025 Lecture: TBD
• 11:15-11:25 ANDREAS 2024
11:25-11:40 BREAK
11.40-12.40 WARCHIP 25 – session 1:
How to limit the consequences of CHIP procedures? Contrast medium overload and X-ray overdose.
• 11:40-11:52 CHIP procedures – scope of the problem for patients & interventionalists
• 11:52-12:04 Modern, passive x-ray solutions to protect patients & operators
• 12:04-12:16 Simple but underused technique to limit contrast use – IVUS, please!
• 12:16-12:28 X-ray overdose – what to do after?
• 12:28-12:40 Discussion
12:40-13:40 BREAK (Lunchboxes will be available)
__________________________________________________
12:40-13:40 Session supported by the unrestricted educational grant by TBD
13:40-13:55 COFFEE BREAK
13:55-14:55 WARCHIP 25 – session 2:
Vascular access & closure are not always the easiest part of the CHIP procedure
• 13:55-14:07 Radial, ulnar or brachial access ? How to choose the right one
• 14:07-14:19 Facilitated femoral access for large bore procedure
• 14:19-14:31 One, two, mixed suture-based closure or just plug-in to closure large bore arteriotomy
14:31-14:55 – Live case – complex PCI – live transmission from Brno
14:55-15:05 BREAK
19:15 AISN BOARD MEETING/POSIEDZENIE ZARZĄDU AISN PTK – hot meal will be not available
8:00-9:50 Walne Zgromadzenie członków Asocjacji Interwencji Sercowo-Naczyniowych Polskiego Towarzystwa Kardiologicznego. General Assembly of the Association on Cardiovascular Interventions of the Polish Cardiac Society.
Session in Polish
9:50-10:00 COFFEE BREAK
10:00-12:00 Kardiologia w Polsce. Perspektywy na przyszłość. Cardiology in Poland. Future perspective.
Session in Polish
• 9:50-10:02 Obecne możliwości leczenia choroby niedokrwiennej serca.
• 10:02-10:14 Obecne możliwości leczenia chorób strukturalnych serca.
• 10:14-10:26 Obecne możliwości leczenia niewydolności serca.
• 10:26-10:46 Pokaz zabiegów:
– 10:46-11:06 Przezskórna angioplastyka wieńcowa wysokiego ryzyka z zastosowaniem urządzenia wspomagającego pracę lewej komory serca (LVAD)
– 11:06-11:20 Zabieg TAVI
• 11:20-12:00 Krajowa Sieć Kardiologiczna.
• Dyskusja. Dokąd idziemy? Jaki będzie docelowy kształt opieki nad pacjentami z chorobami układu sercowo-naczyniowego w Polsce?
12:00-13:00 Lunch and Industry Supported Sessions
• 13:00-17:30 Transseptal puncture for LAAC and Mitral Interventions with Hands-on Training
• 13:00-13:12 How to optimally perform transseptal puncture for Left Atrial Appendage Closure?
13:12-13:52 LIVE/RECORDED CASE 1. TBD
• 13:52-14:04 How to optimally perform transseptal puncture for transcatheter mitral interventions?
14:04-14:44 LIVE/RECORDED CASE 2. TBD
14:44-15:00 COFFEE BREAK
15:00-17:30 Hands-on Training on simulators Earlier sing-up is required
17:30 GALAXY 1: END OF WCCI 2025
_________________________________________
8:00-17:15 Warsaw CTO Symposium (5th Edition), 10th April 2025
Course Co-Directors: Maksymilian Opolski (Warsaw), Paul Knaapen (Amsterdam).
All sessions in English
FULL PROGRAMME WILL BE AVAILABLE ON SEPARATE SHEET ON MONDAY, FEB 24TH
9:50-10:00 COFFEE BREAK
12:00-13:00 Lunch and Industry Supported Sessions
17:15 GALAXY 2: END OF WCCI 2025
18:00 Warsaw CTO Combat Training (by invitation only)
_________________________________________
9:00-16:30 Structural Heart Disease Track
All sessions in English
9:50-10:00 COFFEE BREAK
Session 1.
9:00-11:00 Changing indications to TAVI.
9:00-9:40 LIVE/RECORDED CASE 1.
TAVI in a patient with Coronary Artery Disease and non-femoral access
National Institute of Cardiology, Warsaw.
• 9:40-9:52 TAVI in degenerated surgical aortic bioprostheses.
• 9:52-10:04 TAVI in degenerated transcatheter aortic bioprostheses.
• 10:04-10:14 TAVI for asymptomatic severe aortic stenosis.
• 10:14-10:26 PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.
• 10:26-10:36 Non-femoral access to TAVI:
– Transcaval
– 10:36-10:46 Subclavian.
– 10:46-10:56 Carotid.
• 10:56-11:00 Wrap-up.
11:00-12:00 Session 2.
Leveraging Artificial Intelligence in the Management of Aortic Stenosis
• 11:00-11:12 Advancing Diagnosis of Aortic Stenosis with Artificial Intelligence
• 11:12-11:24 Heart Team Decision-Making Enhanced by Large Language Models.
• 11:24-11:36 Procedural Planning for Aortic Valve Intervention Using Generative AI.
• 11:36-11:48 Post-Procedural Risk Stratification Using Machine Learning.
• 11:48-12:00 Discussion and wrap-up.
12:00-13:00 Lunch and Industry Supported Sessions
13:00-16:30 Mitral, Tricuspid and Complex Interventions
13:00-14:30 Session 3. New evidence for edge-to-edge therapy in (functional?) mitral regurgitation.
14:30-15:10 LIVE/RECORDED CASE 2.
TEER Mitral. TBD
• 15:10-15:22 Lessons learned from COAPT and RESHAPE-2.
• 15:22-15:46 Mitral transcatheter edge-to-edge repair vs. isolated mitral surgery for severe mitral Regurgitation.
• 15:46-15:58 Evolving indications for transcatheter mitral edge-to-edge repair.
• 15:58-16:15 Discussion and wrap-up.
16:15-18:00 Session 4.
Transcatheter edge-to-edge and valve treatment for tricuspid regurgitation.
16:15-17:00 LIVE/RECORDED CASE 3.
Complex transcatheter aortic and mitral/tricuspid treatment. National Institute of Cardiology, Warsaw. TBD
• 17:00-17:12 Review of research and clinical evidence for edge-to-edge therapy for tricuspid regurgitation.
• 17:12-17:24 TEE guidance: tips and tricks.
• 17:24-17:36 ICE guidance: tips and tricks.
• 17:36-18:00 Transcatheter valve therapy for TR: what is clinical evidence with ….
– 17:36-17:48 Orthotopic valves.
– 17:48-18:00 Heterotopic valves.
• 18:00-18:10 Discussion and wrap-up.
18:10 GALAXY 3: END OF WCCI 2025
PROFESSOR ROBERT JULIAN GIL, MD, PhD, FESC
Professor Robert Julian Gil, MD, Ph.D., a graduate of the Pomeranian Medical University in Szczecin has been the head of the Department of Invasive Cardiology of the Clinical Hospital of the Ministry of the Interior and Administration (MSWiA) in Warsaw, one of the most efficient centres of Interventional Cardiology in Poland since 2001. In 1997-2004 he was the Chair of the Invasive Cardiology Section (Working Group) of the Polish Cardiac Society, and a member of its Board (as a past president) for the next 3 years. Since 2001 he has been in the Expert Team handling accreditation in cardiology appointed by the Polish Minister of Health. Since 2002 he has been a Consultant of Healthcare for the Ministry of the Interior and Administration in the field of cardiology.
His scientific interests include mostly the evaluation of atherosclerotic plaque, coronary stenosis, diagnostics and treatment of complex lesions, including bifurcation lesions. He is also interested in the use of percutaneous revascularisation in acute coronary syndromes. For many years he has participated in international clinical studies evaluating medicines and devices supporting coronary angioplasty.
His achievements include over 200 publications in peer-reviewed journals, out of which more than 60 were published in foreign journals (IF close to 200). Moreover, he co-authored 30 chapters of books on interventional cardiology and more than 300 convention reports, out of which more than 100 were presented at prestigious international conventions on clinical electrophysiology and invasive cardiology. Since 2005 he has been a research fellow in the Mossakowski Medical Research Centre of the Polish Academy of Sciences in Warsaw. In June 2013 he was appointed as professor in that Institution.
He initiated annual National Workshops on Interventional Cardiology, which after 5 editions in Szczecin were moved to Warsaw as the Warsaw Course on Cardiovascular Interventions. Their 19th edition is planned for April 2015.
He co-authored the guidelines of the Invasive Cardiology Section of the Polish Cardiac Society concerning Invasive Cardiology.
Since 2007 he has been a member of the exclusive European Bifurcation Club handling the questions of diagnostics and treatment of bifurcation lesions.
Since 1994 he has been a scientific reviewer of monthly Kardiologia Polska, since 1998 – Folia Cardiologica (currently Cardiology Journal), and since 2000 – Polski Przegląd Kardiologiczny. In all of these magazines he is a member of Editorial Boards, and in Kardiologia Polska was the editor of column “Angiogram of the month”. Since 2009 he has regularly reviewed papers sent by to the American Journal of Cardiology, EuroIntervention, Journal of Interventional Cardiology and Circulation.
In 1999 he was appointed as the editor-in-chief of the Invasive Cardiology journal and is performing these functions up till today.
Since 1999 he has been active in the Working Group on coronary circulation of the European Society of Cardiology (ESC), which in September 2006 transformed into the European Association of Percutaneous Cardiovascular Interventions (EAPCI). In 2009 he was assigned to its Grant Committee. In June 2000 he was awarded a prestigious title of the Fellow of European Society of Cardiology. Since 2001 he has been regularly invited to actively participate (Faculty member) in such prestigious Congresses and Workshops of Interventional Cardiology as: EuroPCR, TCT, TCT Russia, ICI in Tel Aviv, European Bifurcation Club meetings and many national congresses.
PROFESSOR ADAM WITKOWSKI, MD, PhD, FESC
CURRICULUM VITAE
General Cardiology & Haemodynamics Dept., Institute of Cardiology,
42 Alpejska St., 04-628 Warsaw, Poland
Phone: +48 22 812 41 64
Fax: +48 22 34 34 506
E-mail: witkowski@hbz.pl
Born: Poznań, Poland Aug 1st, 1958
Education: Warsaw Medical Academy 1976- 83
Proffessional training:
• six weeks of elective training at the Division of Cardiology, University of Maryland Hospital, USA, 1980
• Internship, Medicine and Surgery 1983-84
• 1st degree – Internal Medicine 1986
• two weeks of elective training at the Haemodynamics Division, University Vaudois Hospital, Lausanne, Switzerland, 1989
• 6th Course in Interventional Cardiology, Geneva, Switzerland, 1989
• 2nd degree – Internal Medicine 1990
• Doctor of Philosophy 1993
• Fellowship in Cardiology 1996
• Habilitation 2001 (postdoctoral lecturing qualification)
• Fellow of the European Society of Cardiology 2003
Post held:
• Assistant and Senior Assistant, Haemodynamics&General Cardiology Dept., Institute of Cardiology, Warsaw, Poland 1983-93
• Assistant Professor, Heamodynamics &General Cardiology Dept., Institute of Cardiology, Warsaw, Poland, 1993
• Deputy Director, Haemodynamics Dept., Institute of Cardiology, Warsaw, Poland, 1998
• Associate Professor, Haemodynamics Dept., Institute of Cardiology, Warsaw, Poland, 2001
• Chairmen, Working Group on Interventional, Cardiology of the Polish Cardiac Society 2004-7
Trials:
• Primary Investigator, CAPE, Pfizer 1990-92
• Co-Investigator, GITS Verapamil, Lorex Pharmaceuticals, USA 1992-93
• Co-Investigator, MATTIS, Sanofi Winthrop, 1996
• Co-Investigator, EXCITE, Searle 1998
• Primary Investigator, Tirofiban Study, MSD 1998
• Primary lnvestigator, ICARUS – 1+2, 1999 Medtronic
• Primar Investigator, Race-Car, Medtronic 1999
• Co-lnvestigator, ADVANCE, Boston Scientific 1999
• Primary Investigator, PRESTO, S-KB 2000
• Primary Investigator, VISION, Guidant 2001
• Co-Investigator, Taxus II, Boston Scientific 2001
• Co-Investigator, Euroinject-One 2002
• Co-Investigator, Taxus VI, Boston Scientific 2002
• Co-Investigator, Agent-4, Schering 2002
• Co-Investigator, ARTS II, J&J-Cordis 2003
• Co-Investigator, ENDEAVOR II, Medtronic 2004
• Primary Investigator, FREEDOM 2006
• Primary Investigator, HORIZONS 2006
• Co-Investigator, SYNTAX 2006
Special interest In Cardiology:
Coronary Interventions (PTCA, DCA, TEC, Stenting, HOCM ablation, Brachytherapy)
Research Work:
• Systolic and Diastolic Performance of the Left Ventricle
• Stunned and Hibernating Myocardium
• Perfusion Balloon Catheters
• Coronary Stenting
• DCA
• Hypertrophic Cardiomyopathy
• Coronary Brachytherapy
• Acute coronary syndrome
• Angiogenesis
Awards:
Awards of the Polish Cardiac Society 1995, 2001
Faculty member:
ESC Congresses, EuroPCR